Pathophysiology of Focal Cerebral Ischemia: a Therapeutic Perspective
- 1 January 2004
- journal article
- review article
- Published by Elsevier BV in Journal of Vascular and Interventional Radiology
- Vol. 15 (1), S3-S12
- https://doi.org/10.1097/01.rvi.0000108687.75691.0c
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Tolerability of the Low-Affinity, Use-Dependent NMDA Antagonist AR-R15896AR in Stroke PatientsStroke, 2001
- Very Early Nimodipine Use in Stroke (VENUS)Stroke, 2001
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999
- Remacemide HydrochlorideStroke, 1999
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Safety, Tolerability, and Pharmacokinetics of the N -Methyl- d -Aspartate Antagonist Dextrorphan in Patients With Acute StrokeStroke, 1995
- Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators.Stroke, 1994
- Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction.Stroke, 1990
- Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.Stroke, 1988
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988